SCHEMBL8229740

SCHEMBL8229740

CC(=O)c1ncn(-c2cccc(N3CCOCC3)c2)c1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.47
PIM1 P11309 1/20 0.45
ATR Q13535 1/20 0.45
ALDH1A1 P00352 3/20 0.44
MAPT P10636 2/20 0.44
ALOX15 P16050 1/20 0.44
PRKDC P78527 1/20 0.43
BRD9 Q9H8M2 1/20 0.41
BAZ2B Q9UIF8 1/20 0.41
LRRK2 Q5S007 1/20 0.41
HSD17B10 Q99714 2/20 0.41
BRD4 O60885 1/20 0.41
APOBEC3A P31941 1/20 0.41
CTDSP1 Q9GZU7 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41
USP2 O75604 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3491780 0.91 KMO (0.52) KMOPIM1ATRALDH1A1PRKDC
SCHEMBL3493822 0.88 ALDH1A1 (0.51) KMOPIM1ATRALDH1A1MAPT
SCHEMBL5140406 0.76 CPT1A (0.38) KMOPIM1ATRLRRK2CYP1A2
SCHEMBL3495628 0.76 CPT1A (0.38) KMOPIM1ATRLRRK2CYP1A2
SCHEMBL3494346 0.76 NPC1 (0.41) ALDH1A1MAPTHSD17B10USP2CYP1A2
SCHEMBL3493643 0.76 KIF11 (0.40) KMOPIM1ATRPRKDC
SCHEMBL3492277 0.76 CA1 (0.43) ATRPRKDC
Hydrochloric Acid SCHEMBL3493933 0.75 CA1 (0.42) ATRPRKDC
SCHEMBL3494809 0.75 HCRTR1 (0.43)
SCHEMBL3495289 0.74 TMEM97 (0.39) ATRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007094513-A2 CYCLIC AMINE COMPOUND AND USE THEREOF FOR THE PROPHYLAXIS OR TREATMENT OF HYPERTENSION TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-08-23 WO disclosed